These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15089044)

  • 21. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing the Physiochemical Properties of Puerarin via L-Proline Co-Crystallization: Synthesis, Characterization, and Dissolution Studies of Two Phases of Pharmaceutical Co-Crystals.
    Inam M; Liu L; Wang JW; Yu KX; Phan CU; Shen J; Zhang WH; Tang G; Hu X
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
    J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid state characterization of E2101, a novel antispastic drug.
    Kushida I; Ashizawa K
    J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for polymorphism in glisentide.
    Zornoza A; de Nó C; Martín C; Goñi MM; Martínez Ohárriz MC; Vélaz I
    Int J Pharm; 1999 Sep; 186(2):199-204. PubMed ID: 10486438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring mechanochemical parameters using a DoE approach: Crystal structure solution from synchrotron XRPD and characterization of a new praziquantel polymorph.
    Zanolla D; Perissutti B; Vioglio PC; Chierotti MR; Gigli L; Demitri N; Passerini N; Albertini B; Franceschinis E; Keiser J; Voinovich D
    Eur J Pharm Sci; 2019 Dec; 140():105084. PubMed ID: 31626966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel polymorph of ambrisentan: Characterization and stability.
    Haneef J; Chadha R; Gupta V; Mandal SK
    J Pharm Biomed Anal; 2018 May; 153():102-109. PubMed ID: 29475138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-state study of mepivacaine hydrochloride.
    Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two new polymorphs and one dihydrate of lenalidomide: solid-state characterization study.
    Jia L; Li Z; Gong J
    Pharm Dev Technol; 2019 Nov; 24(9):1175-1180. PubMed ID: 31282833
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism in Simvastatin: Twinning, Disorder, and Enantiotropic Phase Transitions.
    Simões RG; Bernardes CES; Joseph A; M Piedade MF; Kraus W; Emmerling F; Diogo HP; Minas da Piedade ME
    Mol Pharm; 2018 Nov; 15(11):5349-5360. PubMed ID: 30230340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of two polymorphs of lornoxicam.
    Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interconversion studies of betamethasone acetate polymorphs.
    Ke X; Ping Q; Shi H
    Drug Dev Ind Pharm; 2005 Sep; 31(8):813-8. PubMed ID: 16221616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of zopiclone crystal forms found among generic raw materials.
    Terblanche RJ; Liebenberg W; de Villiers MM; Lötter AP
    Drug Dev Ind Pharm; 2000 May; 26(5):531-7. PubMed ID: 10789065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisinopril dihydrate: single-crystal x-ray structure and physicochemical characterization of derived solid forms.
    Sorrenti M; Catenacci L; Cruickshank DL; Caira MR
    J Pharm Sci; 2013 Oct; 102(10):3596-603. PubMed ID: 23873413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
    Aucamp M; Milne M; Liebenberg W
    AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.